Insider · CIK 0001202102

SCANGOS GEORGE A

Reports to the SEC for 7 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001202102

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2026-03-19	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+2,158 sh	$111.75	+$241K	22,800.047
2026-03-19	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,057 sh	$111.75	+$118K	23,857.047
2025-06-03	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2025-03-14	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,819 sh	$121.18	+$220K	20,493.074
2025-02-24	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−10.1K sh	$9.45	−$95.1K	698,239
2025-02-18	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−11K sh	$9.81	−$108K	708,295
2024-10-23	VIRVir Biotechnology, Inc.J Other	Director	JOther	+598K sh	—	—	719,259
2024-10-23	VIRVir Biotechnology, Inc.J Other	Director	JOther	−598K sh	—	—	1,151,730
2024-10-23	VIRVir Biotechnology, Inc.J Other	Director	JOther	+598K sh	—	—	598,270
2024-10-23	VIRVir Biotechnology, Inc.J Other	Director	JOther	−598K sh	—	—	1,151,730
2024-06-05	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2024-05-30	VIRVir Biotechnology, Inc.A Award	Director	AAward	+8,000 sh	—	—	120,989
2024-05-30	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-05-29	AAGILENT TECHNOLOGIES, INC.G Gift	Director	GGift	−3,443 sh	$145.48	−$501K	18,577.87
2024-05-29	AAGILENT TECHNOLOGIES, INC.G Gift	Director	GGift	+3,443 sh	$145.48	+$501K	17,893
2024-03-15	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,678 sh	$147.48	+$247K	21,989.355
2024-02-26	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−17.7K sh	$11.65	−$207K	112,989
2024-02-22	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−10K sh	$10.05	−$101K	130,711
2024-02-20	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−16.9K sh	$10.22	−$172K	140,739
2024-02-16	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−10.9K sh	$10.24	−$111K	157,611
2023-10-17	VIRVir Biotechnology, Inc.J Other	Director	JOther	−1.75M sh	—	—	168,489
2023-10-17	VIRVir Biotechnology, Inc.J Other	Director	JOther	+1.75M sh	—	—	1,750,000
2023-10-17	VIRVir Biotechnology, Inc.J Other	Director	JOther	−1.75M sh	—	—	0
2023-10-17	VIRVir Biotechnology, Inc.J Other	Director	JOther	+1.75M sh	—	—	1,750,000
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	−3.5M sh	—	—	33,629
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	+1.75M sh	—	—	1,918,489
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	+1.75M sh	—	—	1,750,000
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	−112K sh	—	—	0
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	−827K sh	—	—	0
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	−112K sh	—	—	0
2023-09-15	VIRVir Biotechnology, Inc.J Other	Director	JOther	−827K sh	—	—	0
2023-06-06	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2023-05-09	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+44K sh	—	—	44,000
2023-03-16	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,658 sh	$136.82	+$227K	20,184.918
2023-02-24	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−4,239 sh	$22.74	−$96.4K	179,369
2023-02-24	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−10.9K sh	$23.56	−$256K	168,489
2023-02-23	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−12.6K sh	$25.97	−$328K	183,608
2023-02-21	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−11.4K sh	$28.02	−$319K	202,713
2023-02-21	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−6,474 sh	$28.80	−$186K	196,239
2023-02-17	VIRVir Biotechnology, Inc.S Sale	Director	SSale	−9,894 sh	$25.29	−$250K	214,095
2023-01-18	VIRVir Biotechnology, Inc.J Other	Director	JOther	−64.9K sh	—	—	3,533,629
2023-01-18	VIRVir Biotechnology, Inc.J Other	Director	JOther	+64.9K sh	—	—	179,930
2022-12-21	VIRVir Biotechnology, Inc.J Other	Director	JOther	−50K sh	—	—	827,151
2022-12-21	VIRVir Biotechnology, Inc.J Other	Director	JOther	+50K sh	—	—	111,644
2022-12-21	VIRVir Biotechnology, Inc.J Other	Director	JOther	−50K sh	—	—	827,151
2022-12-21	VIRVir Biotechnology, Inc.J Other	Director	JOther	+50K sh	—	—	111,644
2022-03-17	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,785 sh	$136.82	+$244K	18,419.863
2022-03-10	VIRVir Biotechnology, Inc.A Award	Director	AAward	+111K sh	—	—	223,989
2022-03-10	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+222K sh	—	—	222,000

Recent filings

Accepted (ET)
Jun 114
SCANGOS GEORGE A0001104659-26-072934
SEC(opens sec.gov)
Mar 234
SCANGOS GEORGE A0001090872-26-000036
SEC(opens sec.gov)
Jun 44
SCANGOS GEORGE A0001104659-25-056567
SEC(opens sec.gov)
Mar 184
SCANGOS GEORGE A0001127602-25-009725
SEC(opens sec.gov)
Feb 254
SCANGOS GEORGE A0001628280-25-007708
SEC(opens sec.gov)
Feb 194
SCANGOS GEORGE A0001628280-25-006516
SEC(opens sec.gov)
Oct 244
SCANGOS GEORGE A0001628280-24-043632
SEC(opens sec.gov)
Jun 74
SCANGOS GEORGE A0001104659-24-069666
SEC(opens sec.gov)
Jun 34
SCANGOS GEORGE A0001628280-24-026219
SEC(opens sec.gov)
May 314
SCANGOS GEORGE A0001127602-24-017078
SEC(opens sec.gov)
Mar 194
SCANGOS GEORGE A0001127602-24-010687
SEC(opens sec.gov)
Feb 264
SCANGOS GEORGE A0001628280-24-006980
SEC(opens sec.gov)
Feb 204
SCANGOS GEORGE A0001628280-24-005747
SEC(opens sec.gov)

Companies

Address

C/O VOYAGER THERAPEUTICS, INC. 75 HAYDEN AVENUE

LEXINGTON, MA, 02421